MedTrace Logo

T2 and SeptiCyte RAPID Duration Project

NCT04821661 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2026-05-01

No results posted yet for this study

Summary

Infection with bacteria and other germs in the blood can be deadly. How long germs stay in the blood is important for two reasons. The first is that if they stay in the blood for many days it is a sign that antibiotics may need to be changed. The second is that if they stay in the blood for only a short time it may give doctors confidence to switch to tablets and consider early discharge from hospital. This study is evaluating the diagnostic and prognostic performance of two novel technologies when used to measure the duration of the bloodstream infection.

Conditions

  • Bacteremia

Sponsors & Collaborators

  • Metro North Hospital and Health Service

    collaborator UNKNOWN

  • Pathology Queensland

    collaborator UNKNOWN

  • The University of Queensland

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-11
Primary Completion
2023-03-31
Completion
2023-04-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04821661 on ClinicalTrials.gov